A multicentre pilot study of sulphasalazine in juvenile chronic arthritis. 1991

B M Ansell, and M A Hall, and J K Loftus, and P Woo, and V Neumann, and A Harvey, and J A Sills, and D Swinson, and J Insley, and R Amos
Clinical Research Center, Middlesex, U.K.

In this multicentre pilot study of sulphasalazine in juvenile chronic arthritis, the mode of onset and course of the disease, and when available, the HLA status, was recorded on the entry form. After appropriate clinical and laboratory appraisal, sulphasalazine up to 40 mg/kg/day was given for one year with assessments at 0, 1, 3, 6, 9 and 12 months. Fifty-one patients enrolled, 8 of whom were withdrawn because of side effects. In the remainder by 12 months a good effect was noted in 12, 8 having pauci-articular onset disease commencing after the age of 9 years, of whom 6 carried HLA B27. It was relatively ineffective in the other subgroups. The frequency and severity of side effects was similar to that seen in adults. Further evaluation in controlled trials is required in older onset pauci-articular arthritis, taking due note of the patient's HLA status, and also in juvenile psoriatic arthritis and seropositive juvenile rheumatoid arthritis.

UI MeSH Term Description Entries
D007223 Infant A child between 1 and 23 months of age. Infants
D008297 Male Males
D010865 Pilot Projects Small-scale tests of methods and procedures to be used on a larger scale if the pilot study demonstrates that these methods and procedures can work. Pilot Studies,Pilot Study,Pilot Project,Project, Pilot,Projects, Pilot,Studies, Pilot,Study, Pilot
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D001171 Arthritis, Juvenile Arthritis in children, with onset before 16 years of age. The terms juvenile rheumatoid arthritis (JRA) and juvenile idiopathic arthritis (JIA) refer to classification systems for chronic arthritis in children. Only one subtype of juvenile arthritis (polyarticular-onset, rheumatoid factor-positive) clinically resembles adult rheumatoid arthritis and is considered its childhood equivalent. Arthritis, Juvenile Chronic,Arthritis, Juvenile Idiopathic,Arthritis, Juvenile Rheumatoid,Childhood Arthritis,PCJIA,PJIA Polyarticular Juvenile Idiopathic Arthritis,Polyarticular Juvenile Idiopathic Arthritis,Polyarticular-Course Juvenile Idiopathic Arthritis,Still's Disease, Juvenile-Onset,Enthesitis-Related Arthritis, Juvenile,Juvenile Chronic Arthritis,Juvenile Idiopathic Arthritis,Juvenile Rheumatoid Arthritis,Juvenile-Onset Still Disease,Juvenile-Onset Stills Disease,Oligoarthritis, Juvenile,Polyarthritis, Juvenile, Rheumatoid Factor Negative,Polyarthritis, Juvenile, Rheumatoid Factor Positive,Psoriatic Arthritis, Juvenile,Still Disease, Juvenile-Onset,Systemic Arthritis, Juvenile,Arthritides, Childhood,Arthritis, Childhood,Arthritis, Juvenile Enthesitis-Related,Arthritis, Juvenile Psoriatic,Arthritis, Juvenile Systemic,Childhood Arthritides,Chronic Arthritis, Juvenile,Enthesitis Related Arthritis, Juvenile,Idiopathic Arthritis, Juvenile,Juvenile Arthritis,Juvenile Enthesitis-Related Arthritis,Juvenile Oligoarthritis,Juvenile Onset Still Disease,Juvenile Onset Stills Disease,Juvenile Psoriatic Arthritis,Juvenile Systemic Arthritis,Juvenile-Onset Still's Disease,Rheumatoid Arthritis, Juvenile,Still Disease, Juvenile Onset,Still's Disease, Juvenile Onset,Stills Disease, Juvenile-Onset
D012460 Sulfasalazine A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907) Salicylazosulfapyridine,Asulfidine,Azulfadine,Azulfidine,Azulfidine EN,Colo-Pleon,Pleon,Pyralin EN,Salazopyrin,Salazosulfapyridine,Sulfasalazin medac,Sulfasalazin-Heyl,Sulfasalazine FNA,Sulphasalazine,Ucine,Ulcol,ratio-Sulfasalazine,Colo Pleon,Sulfasalazin Heyl,ratio Sulfasalazine

Related Publications

B M Ansell, and M A Hall, and J K Loftus, and P Woo, and V Neumann, and A Harvey, and J A Sills, and D Swinson, and J Insley, and R Amos
January 1991, Acta Universitatis Carolinae. Medica,
B M Ansell, and M A Hall, and J K Loftus, and P Woo, and V Neumann, and A Harvey, and J A Sills, and D Swinson, and J Insley, and R Amos
August 1995, Acta paediatrica (Oslo, Norway : 1992),
B M Ansell, and M A Hall, and J K Loftus, and P Woo, and V Neumann, and A Harvey, and J A Sills, and D Swinson, and J Insley, and R Amos
July 1996, British journal of rheumatology,
B M Ansell, and M A Hall, and J K Loftus, and P Woo, and V Neumann, and A Harvey, and J A Sills, and D Swinson, and J Insley, and R Amos
December 1993, Clinical rheumatology,
B M Ansell, and M A Hall, and J K Loftus, and P Woo, and V Neumann, and A Harvey, and J A Sills, and D Swinson, and J Insley, and R Amos
January 1991, Acta Universitatis Carolinae. Medica,
B M Ansell, and M A Hall, and J K Loftus, and P Woo, and V Neumann, and A Harvey, and J A Sills, and D Swinson, and J Insley, and R Amos
January 1995, Clinical and experimental rheumatology,
B M Ansell, and M A Hall, and J K Loftus, and P Woo, and V Neumann, and A Harvey, and J A Sills, and D Swinson, and J Insley, and R Amos
February 1992, Annals of the rheumatic diseases,
B M Ansell, and M A Hall, and J K Loftus, and P Woo, and V Neumann, and A Harvey, and J A Sills, and D Swinson, and J Insley, and R Amos
January 1999, Advances in experimental medicine and biology,
B M Ansell, and M A Hall, and J K Loftus, and P Woo, and V Neumann, and A Harvey, and J A Sills, and D Swinson, and J Insley, and R Amos
February 1986, The Journal of rheumatology,
B M Ansell, and M A Hall, and J K Loftus, and P Woo, and V Neumann, and A Harvey, and J A Sills, and D Swinson, and J Insley, and R Amos
January 2011, Clinical and experimental rheumatology,
Copied contents to your clipboard!